Results 321 to 330 of about 1,482,290 (356)

Epidermal Growth Factor Inhibitors

2018
Epidermal growth factor receptors (EGFR) are involved in cell growth, differentiation, and proliferation with overexpression/dysregulation seen in many solid malignancies (including pulmonary and most GI cancers) making epidermal growth factor receptor inhibitors (EGFRI) a common treatment choice.
openaire   +1 more source

Myelin associated neurite growth inhibitors

Restorative Neurology and Neuroscience, 1993
L, Schnell, M E, Schwab
openaire   +2 more sources

Bibliographic update: Growth inhibitors

Progress in Growth Factor Research, 1992
openaire   +2 more sources

Cancer treatment and survivorship statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Kimberly D Miller, Leticia M Nogueira, Angela B Mariotto   +2 more
exaly  

A GROWTH INHIBITOR

The Lancet, 1966
openaire   +1 more source

Follow the trail: Using insights from the growth of palliative care to propose a roadmap for cancer rehabilitation

Ca-A Cancer Journal for Clinicians, 2019
Timothy F Marshall, Julie K Silver, Vishwa S Raj   +2 more
exaly  

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Some New Plant-Growth Inhibitors

Science, 1950
openaire   +2 more sources

Growth inhibitors from spikerush

Journal of Agricultural and Food Chemistry, 1980
K. L. Stevens, Glory B. Merrill
openaire   +1 more source

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly